Filters
clear all
Filters
Topics
Markets
Type
Brand
Workers' Comp Article

The Rise of Fentanyl in the Midst of an Already Troubling Opioid Epidemic

March 24, 2022
5 MIN READ

Each day we hear more and more stories of addiction, overdose, and deaths with heartbreaking stories of the individuals and the families who have been impacted by the opioid epidemic. In an attempt to address this crisis, more aggressive clinical intervention and opioid management programs are being adopted, and opioid use has steadily decreased for workers’ compensation patients; however, according to an NSC survey, 75% of employers are being directly impacted by employee opioid misuse.

Workers' Comp Article

Ask The Pharmacist: Brand Name Versus Generic Medications in Workers’ Compensation

February 14, 2022
4 MIN READ

Before answering that it would be good to briefly review some basic information regarding the differences between brand name and generic medications. 

WorkCompWire Article

Dave Torrence: Top Three Workers’ Compensation Trends to Know in 2022

January 18, 2022

As we enter 2022, the workers’ compensation market is still plagued by many of the same issues it has been facing since the start of the COVID-19 pandemic — fluctuating claim volumes, changing regulations and growing uncertainty about the future.

Workers' Comp Article

Washington State Formulary Update

December 3, 2021
1 MIN READ

Washington state has announced updates to its drug formulary, effective January 1, 2022. The following is a list of updated drugs and therapeutic classes (or class codes) and their status on the Washington State Department of Labor and Industries outpatient formulary.

Workers' Comp Article

Could Virtual Reality Be the Next Treatment for Chronic Pain?

November 23, 2021
2 MIN READ

Is virtual reality (VR) the latest tool to help fight chronic pain? A recent FDA approval suggests VR treatment may be part of the expanding use of technology for medical treatments.

Workers' Comp Article

Release of Generic Medications for Workers' Comp in 2022

November 16, 2021
1 MIN READ

Next year twenty-eight drugs relevant to workers’ compensation are expected to become available as generics. These formulations will be made available once the original drug manufacturer’s brand name period of exclusivity has expired.

Enlyte Virtual Event

2021 mPower Virtual Conference

On-Demand
2 MIN READ

The Mitchell | Genex | Coventry team looks forward to connecting with you at the 2021 mPower Conference, taking place virtually October 12–14, 2021.